Table 3. Pearson's coefficient (r) between log-transformed serum NT-proBNP and inflammatory markers according to left ventricular hypertrophy over the entire study: basal, stage I = at 12 months, stage II = at 24 months.

	With LVH (n = 122)			Without LVH (n = 98)
	log NT-proBNP (pg/ml)			log NT-proBNP (pg/ml)
	Basal	Stage I	Stage II	Basal	Stage I	Stage II
log sTNF-R1 (pg/ml)	0.44‡	0.52‡	0.45‡	0.22*	0.24*	0.23*
log IL-6 (pg/ml)	0.29†	0.31†	0.28†	0.11	0.18	0.14

log NT-proBNP, log-transformed N-terminal pro-brain natriuretic; LVH, left ventricular hypertrophy; log IL-6, log-transformed interleukin-6; log sTNF-R1, log-transformed soluble tumor necrosis factor receptor 1.

*p<0.05;

^†p<0.01;

^‡p<0.0001.